Lumida
/AFTR
⌘K
AFTR

AFTR

AFTR
$10.41USD+0.00%+0.00 today

MARKET CAP

325.3M

P/E (TTM)

35.9x

FWD P/E

DAY RANGE

$10 – $10

52W RANGE

$10
$11

The case for & against

Bull & Bear analysis

Bearish

AfterNext HealthTech Acquisition Corp. (AFTR) was a special purpose acquisition company (SPAC) with the aim of merging with a company in the health tech space. SPACs are often formed to raise capital through an initial public offering (IPO) with the intention of acquiring an existing company, thereby offering a faster route to public trading. However, AFTR was liquidated in August 2023 without completing its intended business combination, leading to the delisting of its securities. As a result, the company currently lacks a competitive position, a business model, or operational assets.

Bull says

  • No operations or assets since liquidation in Aug 2023.
  • Completely delisted with zero market liquidity.
  • No business model or revenue streams after failed merger.
  • No earnings, cash flows, or growth catalysts remain.
  • Potential liquidation liabilities could absorb remaining capital.
  • Factor analysis unavailable due to company dissolution.

Bear says

  • Liquidation in Aug 2023 extinguished operating business.
  • Delisted from exchange, eliminating price discovery.
  • SPAC merger deadline missed, causing total loss.
  • Shareholder recoveries eroded by legal fees and obligations.
  • No competitive position or assets in health-tech sector.
  • Heightened SPAC regulatory scrutiny blocks revival.